prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 2144, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 892
2024
-
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients
British journal of haematology, year: 2024, volume: 204, edition: 1, DOI
-
KLONÁLNÍ KOMPETICE A ALTERACE MOLEKULÁRNÍCH DRAH U CHRONICKÉ LYMFOCYTÁRNÍ LEUKEMIE
Year: 2024, type: Conference abstract
-
Léčba dospělých pacientů s akutní lymfoblastovou leukemií v České republice v letech 2007–2020
-
MOLECULAR MECHANISM OF NON-GENETIC ADAPTATION TO BTK INHIBITOR THERAPY IN CLL
Year: 2024, type: Conference abstract
-
Molekulárně genetická diagnostika nesyndromatických ichtyóz
Year: 2024, type: Conference abstract
-
Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study
Hematological Oncology, year: 2024, volume: 42, edition: 3, DOI
-
ROZŠÍŘENÁ MOLEKULÁRNÍ DIAGNOSTIKA DOSPĚLÝCH PACIENTŮ S ALL V ČR
Year: 2024, type: Conference abstract
-
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
Blood advances, year: 2024, volume: 8, edition: 11, DOI
-
STROMAL CELLS ENGINEERED TO EXPRESS T CELL FACTORS INDUCE ROBUST CLL CELL PROLIFERATION IN VITRO AND IN PDX COTRANSPLANTATIONS ALLOWING THE IDENTIFICATION OF ANTI-PROLIFERATIVE DRUGS
Year: 2024, type: Conference abstract
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
Leukemia, year: 2024, volume: 38, edition: 8, DOI